Corbus Pharmaceuticals: Fourth Quarter Financial Results Overview

Corbus Pharmaceuticals Reports Fourth Quarter Financial Results

Corbus Pharmaceuticals Holdings Inc., headquartered in Norwood, Massachusetts, announced on Monday that it recorded a net loss of $20.6 million for the fourth quarter.

The company’s loss equated to $1.25 per share during this period.

Despite the loss, these figures were better than what analysts had anticipated. According to Zacks Investment Research, the consensus among seven analysts was a projected loss of $1.78 per share.

Looking at the full year, Corbus Pharmaceuticals reported a total loss of $78.5 million, or $5.90 per share.